A block-randomized, double-blind, placebo-controlled, single-dose escalating, phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics of YHB1411-2 in healthy male volunteers
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01525147?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
